title: A protective contribution of the Q allele of the R353Q polymorphism of the Factor VII gene in individuals with chronic stable angina?
abstract: BACKGROUND
  Factor VII polymorphisms have been suggested in some studies to show an association with some aspects of coronary disease, and there is a known association between FVII levels and polymorphic variants in the gene. The aim of the study was to assess whether Factor VII polymorphism R353Q is associated with the extent of coronary artery disease in patients with chronic stable angina.
  
  
  RESULTS
  There is evidence that Factor VII polymorphisms are markers of susceptibility to coronary artery disease (CAD), but two studies have suggested that there is no association between the degree of vessel disease and these polymorphisms. One of these studies did not exclude patients with unstable angina or MI. We therefore set up a prospective cohort study to determine Factor VIIa, VIIc and VIIAg levels, genotype for R353Q, lipid status, smoking history and the degree of vessel disease, in patients attending the hospital for routine day case angiography over a 20 month period. From 519 cases, 400 had no previous MI or revascularisation, including 153 with zero vessel disease, and were successfully genotyped: 9 (2%) QQ, 78 (20%) RQ and 313 (78%) RR. Compared with RR subjects, heterozygotes were 2.7 years older (95% CI: 0.3, 5.0; p=0.027), but were not significantly different regarding gender, cholesterol, extent of vessel disease or smoking history. If those with vessel disease were considered, then the heterozygotes were 3.5 years older than the RR homozygotes (95% CI: 0.6-6.4, p=0.016). There was a significant association between all measures of Factor VII and the R353Q polymorphism, with the Q allele associating with lower levels. There was no significant association between the degree of vessel disease and genotype.
  
  
  CONCLUSIONS
  The degree of vessel disease as seen at day case angiography is independent of polymorphism status, but there appears nonetheless to be a moderate protective effect of the Q allele against stable angina, in that angiographic investigation occurs a few years later for RQ heterozygotes than RR homozygotes. The effect may be mediated by reduced levels of Factor VII.
authors.affiliation: Department of Clinical Developmental Sciences (Medical Genetics Unit), St. George's Hospital Medical School, London SW17 ORE, England, UK. s.jeffery@sghms.ac.uk
authors.forename: Steve
authors.initials: S
authors.lastname: Jeffery
authors.forename: Jan
authors.initials: J
authors.lastname: Poloniecki
authors.forename: Ed
authors.initials: E
authors.lastname: Leatham
authors.forename: David
authors.initials: D
authors.lastname: Bevan
authors.forename: Nicola
authors.initials: N
authors.lastname: Ireson
authors.forename: Sheila
authors.initials: S
authors.lastname: Talbot
authors.forename: Della
authors.initials: D
authors.lastname: Cole
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Kaski
mesh_terms: D000483:Alleles; D000787:Angina Pectoris / Q000235:genetics*; D002908:Chronic Disease; D005167:Factor VII / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000502:physiology*; D011446:Prospective Studies
chemical_list: D005167:Factor VII